Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,158 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Benefits of using a self-expandable metallic stent as a bridge to surgery for right- and left-sided obstructive colorectal cancers.
Morita S, Yamamoto K, Ogawa A, Naito A, Mizuno H, Yoshioka S, Matsumura T, Ohta K, Suzuki R, Matsuda C, Hata T, Nishimura J, Mizushima T, Doki Y, Mori M; Clinical Study Group of Osaka University (CSGO), Colorectal Group. Morita S, et al. Among authors: hata t. Surg Today. 2019 Jan;49(1):32-37. doi: 10.1007/s00595-018-1701-4. Epub 2018 Aug 13. Surg Today. 2019. PMID: 30105529
SSEA-3 as a novel amplifying cancer cell surface marker in colorectal cancers.
Suzuki Y, Haraguchi N, Takahashi H, Uemura M, Nishimura J, Hata T, Takemasa I, Mizushima T, Ishii H, Doki Y, Mori M, Yamamoto H. Suzuki Y, et al. Among authors: hata t. Int J Oncol. 2013 Jan;42(1):161-7. doi: 10.3892/ijo.2012.1713. Epub 2012 Nov 22. Int J Oncol. 2013. PMID: 23175153
Depletion of JARID1B induces cellular senescence in human colorectal cancer.
Ohta K, Haraguchi N, Kano Y, Kagawa Y, Konno M, Nishikawa S, Hamabe A, Hasegawa S, Ogawa H, Fukusumi T, Uemura M, Nishimura J, Hata T, Takemasa I, Mizushima T, Noguchi Y, Ozaki M, Kudo T, Sakai D, Satoh T, Fukami M, Ishii M, Yamamoto H, Doki Y, Mori M, Ishii H. Ohta K, et al. Among authors: hata t. Int J Oncol. 2013 Apr;42(4):1212-8. doi: 10.3892/ijo.2013.1799. Epub 2013 Jan 25. Int J Oncol. 2013. PMID: 23354547
C4.4A expression is associated with a poor prognosis of esophageal squamous cell carcinoma.
Ohtsuka M, Yamamoto H, Masuzawa T, Takahashi H, Uemura M, Haraguchi N, Nishimura J, Hata T, Yamasaki M, Miyata H, Takemasa I, Mizushima T, Takiguchi S, Doki Y, Mori M. Ohtsuka M, et al. Among authors: hata t. Ann Surg Oncol. 2013 Aug;20(8):2699-705. doi: 10.1245/s10434-013-2900-2. Epub 2013 Feb 24. Ann Surg Oncol. 2013. PMID: 23435632
A phase II study evaluating the feasibility of a 5-week cycle of S-1 plus irinotecan (IRIS) in patients with advanced and recurrent colorectal cancer.
Hata T, Fukunaga M, Murata K, Uemura Y, Fukuzaki T, Ota H, Ohue M, Ohnishi T, Tanaka N, Takemasa I, Mizushima T, Ikeda M, Yamamoto H, Sekimoto M, Nezu R, Doki Y, Mori M. Hata T, et al. Cancer Chemother Pharmacol. 2013 Jun;71(6):1657-63. doi: 10.1007/s00280-013-2143-8. Epub 2013 Mar 31. Cancer Chemother Pharmacol. 2013. PMID: 23543294 Clinical Trial.
Concurrent expression of C4.4A and Tenascin-C in tumor cells relates to poor prognosis of esophageal squamous cell carcinoma.
Ohtsuka M, Yamamoto H, Oshiro R, Takahashi H, Masuzawa T, Uemura M, Haraguchi N, Nishimura J, Hata T, Yamasaki M, Takemasa I, Miyata H, Mizushima T, Takiguchi S, Doki Y, Mori M. Ohtsuka M, et al. Among authors: hata t. Int J Oncol. 2013 Aug;43(2):439-46. doi: 10.3892/ijo.2013.1956. Epub 2013 May 24. Int J Oncol. 2013. PMID: 23708783
2,158 results